X-chromosome-wide association study for Alzheimer's disease
Language English Country England, Great Britain Media print-electronic
Document type Journal Article
Grant support
RC2 AG036528
NIA NIH HHS - United States
U24 AG021886
NIA NIH HHS - United States
U24 AG072122
NIA NIH HHS - United States
U01 AG032984
NIA NIH HHS - United States
P30 AG066508
NIA NIH HHS - United States
U24 AG041689
NIA NIH HHS - United States
P30 AG072977
NIA NIH HHS - United States
PubMed
39633006
PubMed Central
PMC12092188
DOI
10.1038/s41380-024-02838-5
PII: 10.1038/s41380-024-02838-5
Knihovny.cz E-resources
- MeSH
- Alzheimer Disease * genetics MeSH
- Genome-Wide Association Study methods MeSH
- Genetic Predisposition to Disease genetics MeSH
- X Chromosome Inactivation genetics MeSH
- Polymorphism, Single Nucleotide genetics MeSH
- Humans MeSH
- Chromosomes, Human, X * genetics MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Case-Control Studies MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Due to methodological reasons, the X-chromosome has not been featured in the major genome-wide association studies on Alzheimer's Disease (AD). To address this and better characterize the genetic landscape of AD, we performed an in-depth X-Chromosome-Wide Association Study (XWAS) in 115,841 AD cases or AD proxy cases, including 52,214 clinically-diagnosed AD cases, and 613,671 controls. We considered three approaches to account for the different X-chromosome inactivation (XCI) states in females, i.e. random XCI, skewed XCI, and escape XCI. We did not detect any genome-wide significant signals (P ≤ 5 × 10-8) but identified seven X-chromosome-wide significant loci (P ≤ 1.6 × 10-6). The index variants were common for the Xp22.32, FRMPD4, DMD and Xq25 loci, and rare for the WNK3, PJA1, and DACH2 loci. Overall, this well-powered XWAS found no genetic risk factors for AD on the non-pseudoautosomal region of the X-chromosome, but it identified suggestive signals warranting further investigations.
Alzheimer Research Center and Memory Clinic Andalusian Institute for Neuroscience Málaga Spain
Alzheimer's Centre Reina Sofia CIEN Foundation ISCIII Madrid Spain
Arizona Alzheimer's Consortium Phoenix AZ USA
Banner Alzheimer's Institute Phoenix AZ USA
Boston University and the NHLBI's Framingham Heart Study Boston MA USA
Centro de Biología Molecular Severo Ochoa Madrid Spain
CHU de Bordeaux Pole Santé Publique Bordeaux France
Cleveland Clinic Lou Ruvo Center for Brain Health Cleveland Clinic Cleveland OH USA
Clinic of Neurology UH Alexandrovska Medical University Sofia Sofia Bulgaria
Complex Genetics of Alzheimer's Disease Group VIB Center for Molecular Neurology VIB Antwerp Belgium
Department of Biomedical Sciences University of Antwerp Antwerp Belgium
Department of Biomedical Surgical and Dental Sciences University of Milan Milan Italy
Department of Biostatistics Boston University Boston MA USA
Department of Biostatistics Boston University School of Public Health Boston MA USA
Department of Clinical and Experimental Sciences University of Brescia Brescia Italy
Department of Clinical Biochemistry Copenhagen University Hospital Rigshospitalet Copenhagen Denmark
Department of Clinical Genetics VU University Medical Centre Amsterdam The Netherlands
Department of Clinical Medicine University of Copenhagen Copenhagen Denmark
Department of Clinical Sciences and Community Health University of Milan 20122 Milan Italy
Department of Epidemiology and Biostatistics Case Western Reserve University Cleveland OH USA
Department of Epidemiology and Population Health Stanford University Stanford CA USA
Department of Epidemiology Boston University Boston MA USA
Department of Epidemiology Erasmus MC Rotterdam The Netherlands
Department of Epidemiology University of Washington Seattle WA USA
Department of Geriatric Psychiatry University Hospital of Psychiatry Zürich Zürich Switzerland
Department of Hematology and Stem Cell Transplant Vito Fazzi Hospital Lecce Italy
Department of Human Genetics University of Pittsburgh Pittsburgh PA USA
Department of Medical and Molecular Genetics Indiana University Indianapolis IN USA
Department of Medicine and Surgery Unit of Neurology University Hospital of Parma Parma Italy
Department of Medicine Boston University Boston MA USA
Department of Medicine Cardiovascular Health Research Unit University of Washington Seattle WA USA
Department of Medicine University of Washington Seattle WA USA
Department of Medicine University of Wisconsin Madison WI USA
Department of Neurobiology and Behavior University of California Irvine Irvine CA USA
Department of Neurological Sciences Rush University Medical Center Chicago IL USA
Department of Neurology Albert Einstein College of Medicine New York NY USA
Department of Neurology and Neurological Sciences Stanford University Stanford CA USA
Department of Neurology Bordeaux University Hospital Bordeaux France
Department of Neurology Boston University Boston MA USA
Department of Neurology Boston University School of Medicine Boston MA USA
Department of Neurology Columbia University New York NY USA
Department of Neurology Emory University Atlanta GA USA
Department of Neurology Erasmus MC Rotterdam The Netherlands
Department of Neurology Hospital Universitario Donostia San Sebastian Spain
Department of Neurology Johns Hopkins University Baltimore MD USA
Department of Neurology Massachusetts General Hospital Harvard Medical School Boston MA USA
Department of Neurology Mayo Clinic Rochester MN USA
Department of Neurology Northwestern University Feinberg School of Medicine Chicago IL USA
Department of Neurology University of Alabama at Birmingham Birmingham AL USA
Department of Neurology University of California Davis Sacramento CA USA
Department of Neurology University of Southern California Los Angeles CA USA
Department of Neurology University of Washington Seattle WA USA
Department of Neurology Washington University St Louis MO USA
Department of Neuroscience Mayo Clinic Jacksonville FL USA
Department of Neuroscience Mount Sinai School of Medicine New York NY USA
Department of Neuroscience Rita Levi Montalcini University of Torino Torino Italy
Department of Neuroscience Università Cattolica del Sacro Cuore Rome Italy
Department of Neurosciences University of California San Diego La Jolla CA USA
Department of Ophthalmology Boston University Boston MA USA
Department of Pathology and Immunology Washington University St Louis MO USA
Department of Pathology Boston University Boston MA USA
Department of Pathology Rush University Medical Center Chicago IL USA
Department of Psychiatry and Psychotherapy University Medical Center Goettingen Goettingen Germany
Department of Psychiatry Mount Sinai School of Medicine New York NY USA
Department of Psychiatry New York University New York NY USA
Department of Psychiatry University of Arizona Phoenix AZ USA
Department of Public Health and Caring Sciences Geriatrics Uppsala University Uppsala Sweden
Department of Public Health Sciences University of Miami Miller School of Medicine Miami FL USA
Department of Radiology Indiana University Indianapolis IN USA
Department of Radiology University of Washington Seattle WA USA
Dr John T Macdonald Foundation Department of Human Genetics University of Miami Miami FL USA
Estudios en Neurociencias y Sistemas Complejos CONICET HEC UNAJ Buenos Aires Argentina
Faculty of Medicine University of Lisbon Lisbon Portugal
Fondazione IRCCS Istituto Neurologico Carlo Besta Milan Italy
Fundació Docència i Recerca MútuaTerrassa Terrassa Barcelona Spain
Geriatric Research Education and Clinical Center University of Wisconsin Madison WI USA
Geriatric Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico 20122 Milan Italy
German Center for Neurodegenerative Diseases Berlin Germany
German Center for Neurodegenerative Diseases Bonn Germany
German Center for Neurodegenerative Diseases Goettingen Germany
German Center for Neurodegenerative Diseases Magdeburg Germany
German Center for Neurodegenerative Diseases Munich Germany
Gertrude H Sergievsky Center Columbia University New York NY USA
Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases San Antonio TX USA
Institut de Recerca Biomedica de Lleida Lleida Spain
Institute for Regenerative Medicine University of Zürich Zurich Switzerland
Institute for Stroke and Dementia Research University Hospital LMU Munich Munich Germany
Institute for Urban Public Health University Hospital of University Duisburg Essen Essen Germany
Institute of Biomedicine University of Eastern Finland Kuopio Finland
Institute of Clinical Medicine Neurology University of Eastern Finland Kuopio Finland
Institute of Clinical Medicine University of Oslo Oslo Norway
Institute of Neurology Catholic University of the Sacred Heart Rome Italy
Instituto de Investigacion Sanitaria 'Hospital la Paz' Madrid Spain
Instituto de Investigación Sanitaria del Principado de Asturias Oviedo Spain
IRCCS Fondazione Don Carlo Gnocchi Florence Italy
Klinik für Psychiatrie und Psychotherapie Saarbrücken Germany
Krembil Brain Institute University Health Network Toronto ON Canada
Laboratorio de Genética Hospital Universitario Central de Asturias Oviedo Spain
Laboratory of Experimental Neuropsychobiology IRCCS Santa Lucia Foundation Rome Italy
Medical Science Department iBiMED Aveiro Portugal
Michigan Alzheimer's Disease Center Department of Neurology University of Michigan Ann Arbor MI USA
Munich Cluster for Systems Neurology Munich Germany
Neurodegenerative Diseases Unit Fondazione IRCCS Ca' Granda Ospedale Policlinico Milan Italy
Neurogenomics Division Translational Genomics Research Institute Phoenix AZ USA
Neurological Tissue Bank Biobank Hospital Clinic FRCB IDIBAPS Barcelona Spain
Neurology Service Marqués de Valdecilla University Hospital Santander Spain
Neurology Unit IRCCS Fondazione Policlinico Universitario A Gemelli Rome Italy
Neurology Unit San Gerardo Hospital Monza and University of Milano Bicocca Milan Italy
Neuroscience Center Zurich University of Zurich and ETH Zurich Zurich Switzerland
Neurosciences Area Instituto Biodonostia San Sebastian Spain
NORMENT Centre Division of Mental Health and Addiction Oslo University Hospital Oslo Norway
Nuffield Department of Population Health Oxford University Oxford UK
Old Age Psychiatry Department of Psychiatry Lausanne University Hospital Lausanne Switzerland
Program in Cellular Neuroscience Neurodegeneration and Repair Yale University New Haven CT USA
Program in Medical and Population Genetics Broad Institute Cambridge MA USA
Rush Alzheimer's Disease Center Rush University Medical Center Chicago IL USA
The John P Hussman Institute for Human Genomics University of Miami Miami FL USA
Translational Health Sciences Bristol Medical School University of Bristol Bristol UK
UK Dementia Research Institute Cardiff University Cardiff UK
Unidad Mixta de Neurologia Genètica Instituto de Investigación Sanitaria La Fe Valencia Spain
Unitat de Genètica Molecular Institut de Biomedicina de València CSIC Valencia Spain
Unitat Trastorns Cognitius Hospital Universitari Santa Maria de Lleida Lleida Spain
Univ Lille Inserm 1171 CHU Clinical and Research Memory Research Centre of Distalz Lille France
Universidad Autónoma de Madrid Madrid Spain
Université de Paris EA 4468 APHP Hôpital Broca Paris France
Université Paris Saclay CEA Centre National de Recherche en Génomique Humaine 91057 Evry France
University Bordeaux Inserm Bordeaux Population Health Research Center Bordeaux France
University of Miami Miller School of Medicine Miami FL USA
University of Pittsburgh Alzheimer's Disease Research Center Pittsburgh PA USA
Wisconsin Alzheimer's Disease Research Center Madison WI USA
Zurich Center for Integrative Human Physiology University of Zurich Zurich Switzerland
See more in PubMed
Lambert JC, Ramirez A, Grenier-Boley B, Bellenguez C. Step by step: towards a better understanding of the genetic architecture of Alzheimer’s disease. Mol Psychiatry. 2023;28:2716–27. PubMed PMC
Bellenguez C, Küçükali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat Genet. 2022;54:412–36. PubMed PMC
Holstege H, Hulsman M, Charbonnier C, Grenier-Boley B, Quenez O, Grozeva D, et al. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease. Nat Genet. 2022;54:1786–94 PubMed PMC
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet. 2019;51:414–30. PubMed PMC
Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Holland D, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease. Nat Genet. 2021;53:1276–82. PubMed PMC
Sims R, Van Der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer’s disease. Nat Genet. 2017;49:1373–84. PubMed PMC
Carrel L, Brown CJ. When the lyon(Ized chromosome) roars: ongoing expression from an inactive X chromosome. Philos Trans R Soc B Biol Sci. 2017;372:20160355. PubMed PMC
Lyon MF. Gene action in the X-chromosom (Mus musculus L.). Nature. 1961;190:372–3. PubMed
Amos-Landgraf JM, Cottle A, Plenge RM, Friez M, Schwartz CE, Longshore J, et al. X chromosome-inactivation patterns of 1,005 phenotypically unaffected females. Am J Hum Genet. 2006;79:493–9. PubMed PMC
Shvetsova E, Sofronova A, Monajemi R, Gagalova K, Draisma HHM, White SJ, et al. Skewed X-inactivation is common in the general female population. Eur J Hum Genet. 2019;27:455–65. PubMed PMC
Zito A, Davies MN, Tsai PC, Roberts S, Andres-Ejarque R, Nardone S, et al. Heritability of skewed X-inactivation in female twins is tissue-specific and associated with age. Nat Commun. 2019;10:1–11. PubMed PMC
Busque L, Mio R, Mattioli J, Brais E, Biais N, Lalonde Y, et al. Nonrandom X-inactivation patterns in normal females: Lyonization ratios vary with age. Blood. 1996;88:59–65. PubMed
Tukiainen T, Villani AC, Yen A, Rivas MA, Marshall JL, Satija R, et al. Landscape of X chromosome inactivation across human tissues. Nature. 2017;550:244–8. PubMed PMC
Sun L, Wang Z, Lu T, Manolio TA, Paterson AD. eXclusionarY: 10 years later, where are the sex chromosomes in GWASs? Am J Hum Genet. 2023;110:903–12. PubMed PMC
Chen B, Craiu RV, Strug LJ, Sun L. The X factor: a robust and powerful approach to X-chromosome-inclusive whole-genome association studies. Genet Epidemiol. 2021;45:694–709. PubMed PMC
Smith SM, Douaud G, Chen W, Hanayik T, Alfaro-Almagro F, Sharp K, et al. An expanded set of genome-wide association studies of brain imaging phenotypes in UK Biobank. Nat Neurosci. 2021;24:737–45. PubMed PMC
Mallard TT, Liu S, Seidlitz J, Ma Z, Moraczewski D, Thomas A, et al. X-chromosome influences on neuroanatomical variation in humans. Nat Neurosci. 2021;24:1216–24. PubMed
Neri G, Schwartz CE, Lubs HA, Stevenson RE. XLID update 2017. Am J Med Genet A. 2018;176:1375. PubMed PMC
Hickman RA, O’Shea SA, Mehler MF, Chung WK. Neurogenetic disorders across the lifespan: from aberrant development to degeneration. Nat Rev Neurol. 2022;18:117–24. PubMed PMC
Ferretti MT, Santuccione Chadha A. The missing X factor in Alzheimer disease. Nat Rev Neurol. 2021;17:727–8. PubMed
Alzheimer Europe. Dementia in Europe yearbook 2019: estimating the prevalence of dementia in Europe. Alzheimer Europe; 2019. pp. 108.
Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7:e105–25. PubMed PMC
Corrada MM, Brookmeyer R, Paganini-Hill A, Berlau D, Kawas CH. Dementia incidence continues to increase with age in the oldest old the 90+ study. Ann Neurol. 2010;67:114–21. PubMed PMC
Gilsanz P, Corrada MM, Kawas CH, Mayeda ER, Glymour MM, Quesenberry CP, et al. Incidence of dementia after age 90 in a multiracial cohort. Alzheimers Dement. 2019;15:497–505. PubMed PMC
Mayeda ER, Glymour MM, Quesenberry CP, Whitmer RA. Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Physiol Behav. 2016;176:100–6. PubMed PMC
Matthews FE, Stephan BCM, Robinson L, Jagger C, Barnes LE, Arthur A, et al. A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II. Nat Commun. 2016;7:11398. PubMed PMC
Wolters FJ, Chibnik LB, Waziry R, Anderson R, Berr C, Beiser A, et al. Twenty-seven-year time trends in dementia incidence in Europe and the United States: the Alzheimer Cohorts Consortium. Neurology. 2020;95:E519–31. PubMed PMC
Shaw C, Hayes-Larson E, Glymour MM, Dufouil C, Hohman TJ, Whitmer RA, et al. Evaluation of selective survival and sex/gender differences in dementia incidence using a simulation model. JAMA Netw Open. 2021;4:e211001. PubMed PMC
Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005;62:685–91. PubMed
Liesinger AM, Graff-Radford NR, Duara R, Carter RE, Hanna Al-Shaikh FS, Koga S, et al. Sex and age interact to determine clinicopathologic differences in Alzheimer’s disease. Acta Neuropathol. 2018;136:873–85. PubMed PMC
Oveisgharan S, Arvanitakis Z, Yu L, Farfel J, Schneider JA, Bennett DA. Sex differences in Alzheimer’s disease and common neuropathologies of aging. Acta Neuropathol. 2018;136:887–900. PubMed PMC
Buckley RF, Mormino EC, Rabin JS, Hohman TJ, Landau S, Hanseeuw BJ, et al. Sex differences in the association of global amyloid and regional tau deposition measured by positron emission tomography in clinically normal older adults. JAMA Neurol. 2019;76:542–51. PubMed PMC
Wisch JK, Meeker KL, Gordon BA, Flores S, Dincer A, Grant EA, et al. Sex-related differences in tau positron emission tomography (PET) and the effects of hormone therapy (HT). Alzheimer Dis Assoc Disord. 2021;35:164–8. PubMed PMC
Pereira JB, Harrison TM, La Joie R, Baker SL, Jagust WJ. Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults. Eur J Nucl Med Mol Imaging. 2020;47:2155–64. PubMed PMC
Edwards L, La Joie R, Iaccarino L, Strom A, Baker SL, Casaletto KB, et al. Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer’s continuum: greater tau-PET retention in females. Neurobiol Aging. 2021;105:86–98. PubMed PMC
Filon JR, Intorcia AJ, Sue LI, Vazquez Arreola E, Wilson J, Davis KJ, et al. Gender differences in Alzheimer disease: brain atrophy, histopathology burden, and cognition. J Neuropathol Exp Neurol. 2016;75:748–54. PubMed PMC
Babapour Mofrad R, Tijms BM, Scheltens P, Barkhof F, Van Der Flier WM, Sikkes SAM, et al. Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ϵ4 genotype. Neurology. 2020;95:e2378–88. PubMed
Hohman TJ, Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B, et al. Sex-specific association of apolipoprotein E with cerebrospinal fluid levels of tau. JAMA Neurol. 2018;75:989–98. PubMed PMC
Levine DA, Gross AL, Briceño EM, Tilton N, Giordani BJ, Sussman JB, et al. Sex differences in cognitive decline among US adults. JAMA Netw Open. 2021;4:1–13. PubMed PMC
Bloomberg M, Dugravot A, Dumurgier J, Kivimaki M, Fayosse A, Steptoe A, et al. Sex differences and the role of education in cognitive ageing: analysis of two UK-based prospective cohort studies. Lancet Public Health. 2021;6:e106–15. PubMed PMC
Lipnicki DM, Crawford JD, Dutta R, Thalamuthu A, Kochan NA, Andrews G, et al. Age-related cognitive decline and associations with sex, education and apolipoprotein E genotype across ethnocultural groups and geographic regions: a collaborative cohort study. PLoS Med. 2017;14:1–21. PubMed PMC
Ferretti MT, Iulita MF, Cavedo E, Chiesa PA, Dimech AS, Chadha AS, et al. Sex differences in Alzheimer disease—the gateway to precision medicine. Nat Rev Neurol. 2018;14:457–69. PubMed
Arenaza-Urquijo EM, Boyle R, Casaletto K, Anstey KJ, Vila-Castelar C, Colverson A, et al. Sex and gender differences in cognitive resilience to aging and Alzheimer’s disease. Alzheimers Dement. 2024;20:5695–719. PubMed PMC
Ferretti MT, Martinkova J, Biskup E, Benke T, Gialdini G, Nedelska Z, et al. Sex and gender differences in Alzheimer’s disease: current challenges and implications for clinical practice: position paper of the Dementia and Cognitive Disorders Panel of the European Academy of Neurology. Eur J Neurol. 2020;27:928–43. PubMed
Tifratene K, Robert P, Metelkina A, Pradier C, Dartigues JF. Progression of mild cognitive impairment to dementia due to AD in clinical settings. Neurology. 2015;85:331–8. PubMed
Lin KA, Choudhury KR, Rathakrishnan BG, Marks DM, Petrella JR, Doraiswamy PM. Marked gender differences in progression of mild cognitive impairment over 8 years. Alzheimers Dement Transl Res Clin Interv. 2015;1:103–10. PubMed PMC
Davis EJ, Broestl L, Williams G, Garay BI, Lobach I, Devidze N, et al. A second X chromosome contributes to resilience in a mouse model of Alzheimer’s disease. Sci Transl Med. 2020;12:eaaz5677. PubMed PMC
Zheng X, Wang S, Huang J, Li C, Shang H. Predictors for survival in patients with Alzheimer’s disease: a large comprehensive meta-analysis. Transl Psychiatry. 2024;14:1–9. PubMed PMC
Davis EJ, Solsberg CW, White CC, Miñones-Moyano E, Sirota M, Chibnik L, et al. Sex-specific association of the X chromosome with cognitive change and tau pathology in aging and Alzheimer disease. JAMA Neurol. 2021;78:1249–54. PubMed PMC
Yan Y, Wang X, Chaput D, Pieper AA, Woo JA, Kang DE, et al. X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women increases tauopathy vulnerability in women. Cell. 2022;185:3913–30.e19. PubMed PMC
Liu JZ, Erlich Y, Pickrell JK. Case-control association mapping by proxy using family history of disease. Nat Genet. 2017;49:325–31. PubMed
Jansen IE, van der Lee SJ, Gomez-Fonseca D, de Rojas I, Dalmasso MC, Grenier-Boley B, et al. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers. Acta Neuropathol. 2022;144:821–42. PubMed PMC
Luck T, Riedel-Heller SG, Kaduszkiewicz H, Bickel H, Jessen F, Pentzek M, et al. Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Dement Geriatr Cogn Disord. 2007;24:307–16. PubMed
Grande G, Vetrano DL, Fratiglioni L, Marseglia A, Vanacore N, Laukka EJ, et al. Disability trajectories and mortality in older adults with different cognitive and physical profiles. Aging Clin Exp Res. 2020;32:1007–16. PubMed PMC
Artero S, Ancelin ML, Portet F, Dupuy A, Berr C, Dartigues JF, et al. Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry. 2008;79:979–84. PubMed
Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023:613;508–18. PubMed PMC
Taliun D, Harris DN, Kessler MD, Carlson J, Szpiech ZA, Torres R, et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature. 2021;590:290–9. PubMed PMC
Auton A, Abecasis GR, Altshuler DM, Durbin RM, Bentley DR, Chakravarti A, et al. A global reference for human genetic variation. Nature. 2015;526:68–74. PubMed PMC
Loh PR, Danecek P, Palamara PF, Fuchsberger C, Reshef YA, Finucane HK, et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat Genet. 2016;48:1443–8. PubMed PMC
Walter K, Min JL, Huang J, Crooks L, Memari Y, McCarthy S, et al. The UK10K project identifies rare variants in health and disease. Nature. 2015;526:82–89. PubMed PMC
Clayton DG. Sex chromosomes and genetic association studies. Genome Med. 2009;1:1–7. PubMed PMC
Clayton DG. Testing for association on the X chromosome. Biostatistics. 2008;9:593–600. PubMed PMC
Ghosh A, Hartge P, Kraft P, Joshi AD, Ziegler RG, Chanock SJ, et al. Leveraging family history in population-based case-control association studies. Genet Epidemiol. 2014;38:114–22. PubMed PMC
Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190–1. PubMed PMC
Magi R, Lindgren CM, Morris AP. Meta-analysis of sex-specific genome-wide association studies. Genet Epidemiol. 2010;34:846–53. PubMed PMC
Satizabal CL, Adams HH, Hibar DP, White CC. Genetic architecture of subcortical brain structures in 38,851 individuals. Physiol Behav. 2019;176:139–48. PubMed PMC
Aulchenko YS, Ripke S, Isaacs A, van Duijn CM. GenABEL: an R library for genome-wide association analysis. Bioinformatics. 2007;23:1294–6. PubMed
Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet. 2007;39:906–13. PubMed
Philipps V, Amieva H, Andrieu S, Dufouil C, Berr C, Dartigues JF, et al. Normalized mini-mental state examination for assessing cognitive change in population-based brain aging studies. Neuroepidemiology. 2014;43:15–25. PubMed
Kleineidam L, Chouraki V, Próchnicki T, van der Lee SJ, Madrid-Márquez L, Wagner-Thelen H, et al. PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment. Acta Neuropathol. 2020;139:1025–44. PubMed PMC
Wingo AP, Liu Y, Gerasimov ES, Vattathil SM, Liu J, Cutler DJ, et al. Sex differences in brain protein expression and disease. Nat Med. 2023;29:2224–32. PubMed PMC
Lukacsovich D, O’Shea D, Huang H, Zhang W, Youn JI, Chen XS, et al. MIAMI-AD (methylation in aging and methylation in AD): an integrative knowledgebase that facilitates explorations of DNA methylation across sex, aging, and Alzheimer’s disease. MedRxiv. 2023. PubMed PMC
de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015;11:1–19. PubMed PMC
Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64–74. PubMed
Group WW. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ. 1989;67:601–11. PubMed PMC
Lee HW, Jeonghoon C, Hyewon S, Karam K, Jinhee Y, Moonseok N, et al. Preso, a novel PSD-95-interacting FERM and PDZ domain protein that regulates dendritic spine morphogenesis. J Neurosci. 2008;28:14546–56. PubMed PMC
Piard J, Hu JH, Campeau PM, Rzońca S, Van Esch H, Vincent E, et al. FRMPD4 mutations cause X-linked intellectual disability and disrupt dendritic spine morphogenesis. Hum Mol Genet. 2018;27:589–600. PubMed PMC
Okbay A, Wu Y, Wang N, Jayashankar H, Bennett M, Nehzati SM, et al. Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individuals. Nat Genet. 2022;54:437–49. PubMed PMC
Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat Genet. 2019;51:404–13. PubMed PMC
Smith ER, Cayrou C, Huang R, Lane WS, Côté J, Lucchesi JC. A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16. Mol Cell Biol. 2005;25:9175–88. PubMed PMC
Hayward GC, Caceres D, Copeland EN, Baranowski BJ, Mohammad A, Whitley KC, et al. Characterization of Alzheimer’s disease-like neuropathology in Duchenne’s muscular dystrophy using the DBA/2J mdx mouse model. FEBS Open Bio. 2022;12:154–62. PubMed PMC
Wang K-W, Yuan Y-X, Zhu B, Zhang Y, Wei Y-F, Meng F-S, et al. X chromosome-wide association study of quantitative biomarkers from the Alzheimer’s Disease Neuroimaging Initiative study. Front Aging Neurosci. 2023;15:1–15. PubMed PMC
Begum G, Yuan H, Kahle KT, Li L, Wang S, Shi Y, et al. Inhibition of WNK3 kinase signaling reduces brain damage and accelerates neurological recovery after stroke. Stroke. 2015;46:1956–65. PubMed PMC
Wu D, Lai N, Deng R, Liang T, Pan P, Yuan G, et al. Activated WNK3 induced by intracerebral hemorrhage deteriorates brain injury maybe via WNK3/SPAK/NKCC1 pathway. Exp Neurol. 2020;332:113386. PubMed
Zhu J, Lin X, Chen C, Tan H, Gao Y, Li D, et al. WNK3 promotes neuronal survival after traumatic brain injury in rats. Neuroscience. 2021;477:76–88. PubMed
Naqvi S, Sleyp Y, Hoskens H, Indencleef K, Spence JP, Bruffaerts R, et al. Shared heritability of human face and brain shape. Nat Genet. 2021;53:830–9. PubMed PMC
Sha Z, Schijven D, Fisher SE, Francks C. Genetic architecture of the white matter connectome of the human brain. Sci Adv. 2023;9:eadd2870. PubMed PMC
Belloy ME, Guen YL, Stewart I, Herz J, Sherva R, Zhang R, et al. The role of X chromosome in Alzheimer′s disease genetics. JAMA Neurol. 2024;11:2024.04.22.24306094. PubMed PMC
Gorlov IP, Amos CI. Why does the X chromosome lag behind autosomes in GWAS findings? PLoS Genet. 2023;19:1–19. PubMed PMC
Seto M, Hohman TJ, Mormino EC, Papp KV, Rentz READM, Johnson KA, et al. Parental history of memory impairment and β-amyloid in cognitively unimpaired older adults. JAMA Neurol. 2024;81:798–804. PubMed PMC
Dubal DB, Elser HC. β-Amyloid in cognitively unimpaired individuals-blame mom? JAMA Neurol. 2024;81:795–7. PubMed